V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220014297 | 220008833 | 1.73 | 75.9 | Not known (9) | 2014-12-26 | 2014-12-26 | PONATINIB | N | N | 220033188 | FBC |
| 220014298 | 220008833 | 1.75 | null | Curative (C) | 2018-11-21 | 2019-01-29 | Paclitaxel 7 day | 02 | N | 220033188 | PACLITAXEL |
| 220014299 | 220008833 | 1.78 | null | Curative (C) | 2014-10-17 | 2015-04-05 | Clofarabine + Cytarabine | N | null | 220033188 | METHOTREXATE |
| 220014300 | 220008834 | 1.63 | 72.2 | Curative (C) | 2013-07-14 | 2013-07-27 | Docetaxel 100mg/m2 (21 day) | N | N | 220033208 | FBC |
| 220014301 | 220008835 | 2.03 | null | Palliative (P) | 2015-01-30 | 2015-01-31 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033208 | ALEMTUZUMAB |
| 220014302 | 220008835 | 1.7 | 57 | Palliative (P) | 2016-02-26 | 2016-02-26 | CISPLATIN + GEMCITABINE | 2 | N | 220033208 | GEMTUZUMAB OZOGAMICIN |
| 220014303 | 220008836 | 1.83 | 61 | null | 2018-02-03 | 2018-02-03 | IDARUBICIN | 02 | null | 220033223 | IDARUBICIN |
| 220014306 | 220008838 | 1.74 | 57 | Disease modification (D) | null | 2015-08-22 | CISPLATIN + GEMCITABINE | N | N | 220033231 | PONATINIB |
| 220014307 | 220008839 | 1.6 | 70 | Curative (C) | 2018-01-22 | 2018-02-05 | CARBOPLATIN + PACLITAXEL | 02 | N | 220033242 | CARBOPLATIN + PACLITAXEL |
| 220014308 | 220014740 | 1.68 | 108.4 | Curative (C) | 2016-02-09 | 2016-02-09 | Paclitaxel (2 or 3 weekly) | null | N | 220033243 | PACLITAXEL |
| 220014309 | 220008840 | 1.62 | 68 | Curative (C) | 2015-09-17 | 2015-09-17 | Cytarabine intrathecal | null | null | 220033249 | CYTARABINE INTRATHECAL |
| 220014310 | 220008843 | 1.66 | 51 | Curative (C) | 2015-10-17 | 2015-10-17 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033250 | ALEMTUZUMAB |
| 220014311 | 220008847 | 1.8 | 80 | Curative (C) | 2014-10-10 | 2014-10-10 | UKALL14- Intens/CNS Proph | 02 | N | 220033256 | UKALL2014 |
| 220014312 | 220008848 | 1.73 | 71.4 | Curative (C) | 2014-11-04 | 2014-11-04 | PACLITAXEL | 2 | N | 220033257 | PACLITAXEL |
| 220014313 | 220008848 | null | 100.45 | Curative (C) | 2017-03-14 | 2017-03-14 | METHOTREXATE | 01 | N | 220033257 | DOCETAXEL |
| 220014314 | 220008851 | null | null | Curative (C) | 2016-03-15 | 2016-03-15 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033260 | CARBOPLATIN + PACLITAXEL |
| 220014315 | 220008853 | 1.67 | 71.2 | Curative (C) | null | 2017-07-24 | UKALL14- Intens/CNS Proph +Imatinib | 2 | N | 220033268 | CISPLATIN + GEMCITABINE |
| 220014316 | 220008855 | 1.65 | 48.7 | Disease modification (D) | 2018-01-28 | 2018-01-28 | Mitox + Tretinoin Spanish Course 3 | N | N | 220033272 | MITOXANTRONE |
| 220014317 | 220014745 | 1.61 | 88 | Disease modification (D) | 2015-01-31 | 2015-02-04 | CARBOPLATIN + ETOPOSIDE | 02 | N | 220033272 | CARBOPLATIN + ETOPOSIDE |
| 220014318 | 220014745 | 1.73 | 68.7 | Curative (C) | null | 2013-08-22 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033272 | ALEMTUZUMAB |
| 220014319 | 220014746 | 1.61 | 45 | Disease modification (D) | null | 2016-10-20 | Fludarabine + Melphalan RIC Allo | N | N | 220033287 | GEMTUZUMAB OZOGAMICIN |
| 220014320 | 220008858 | 1.66 | null | Curative (C) | 2014-01-19 | 2014-02-23 | UKALL14- Intens/CNS Proph | 2 | null | 220033294 | OXALIPLATIN + MDG |
| 220014321 | 220008858 | 1.94 | 95.1 | Curative (C) | 2015-08-12 | 2015-08-16 | Arsenic trioxide + Tretinoin | N | N | 220033294 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014322 | 220008858 | 1.65 | 77.5 | Curative (C) | 2014-07-30 | 2014-07-30 | CARBOPLATIN + PACLITAXEL | N | N | 220033294 | CARBOPLATIN + PACLITAXEL |
| 220014323 | 220008858 | 1.64 | 69 | Curative (C) | 2014-05-11 | 2014-05-13 | CARBOPLATIN + PACLITAXEL | 2 | N | 220033294 | CARBOPLATIN + PACLITAXEL |
| 220014324 | 220008860 | null | 82.7 | Curative (C) | 2015-06-04 | 2015-06-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033334 | CARBOPLATIN + PACLITAXEL |
| 220014325 | 220008861 | 1.67 | null | Curative (C) | 2016-03-20 | 2016-03-20 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033334 | ALEMTUZUMAB |
| 220014326 | 220008862 | null | 108 | Curative (C) | 2017-07-10 | 2017-07-10 | Arsenic trioxide + Tretinoin | 2 | N | 220033340 | ARSENIC TRIOXIDE + TRETINOIN |
| 220014327 | 220008864 | 0 | 79.3 | Curative (C) | 2016-06-15 | 2016-06-19 | Cytarabine intrathecal | 2 | N | 220033345 | CYTARABINE INTRATHECAL |
| 220014328 | 220008865 | 1.54 | 50.3 | null | null | 2013-06-13 | PONATINIB | null | null | 220033348 | DOCETAXEL |
| 220014329 | 220008866 | 1.78 | 106 | Curative (C) | 2016-04-20 | 2016-04-20 | Cytarabine intrathecal | N | N | 220033348 | CYTARABINE INTRATHECAL |
| 220014330 | 220008866 | 1.66 | 98.9 | Curative (C) | 2016-10-29 | 2016-11-01 | Paclitaxel 7 day | N | N | 220033348 | PACLITAXEL |
| 220014331 | 220008867 | 1.76 | null | Curative (C) | null | 2016-03-13 | CARBOPLATIN + PACLITAXEL | 2 | N | 220033374 | CARBOPLATIN + PACLITAXEL |
| 220014332 | 220008868 | null | 77.6 | null | null | 2014-10-21 | Fludarabine + Melphalan RIC Allo | null | null | 220033375 | PONATINIB |
| 220014333 | 220014751 | 1.79 | 78 | Curative (C) | 2016-10-11 | 2016-10-12 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033376 | ALEMTUZUMAB |
| 220014334 | 220014751 | 1.7 | 77.8 | Disease modification (D) | 2015-01-25 | 2015-07-15 | PACLITAXEL | N | N | 220033376 | PACLITAXEL |
| 220014335 | 220014751 | 1.65 | 78.4 | Curative (C) | null | 2016-01-19 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 220033376 | PACLITAXEL |
| 220014336 | 220008870 | 1.63 | 62 | Palliative (P) | 2016-01-12 | 2016-01-12 | PONATINIB | N | N | 220033397 | CLOFARABINE + CYTARABINE |
| 220014337 | 220018065 | 1.69 | 85 | null | 2014-07-12 | 2014-08-08 | PONATINIB | N | N | 220033397 | METHOTREXATE |
| 220014338 | 220021578 | 1.55 | 57.8 | Disease modification (D) | 2014-02-26 | 2014-03-04 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220033403 | PONATINIB |
| 220014339 | 220008873 | 1.5 | 43 | Palliative (P) | 2013-05-24 | 2013-05-31 | Mitoxantrone | N | N | 220033410 | MITOXANTRONE |
| 220014340 | 220014753 | 1.67 | 109.8 | Disease modification (D) | 2017-11-12 | 2017-11-12 | Cytarabine intrathecal | N | N | 220033414 | CYTARABINE INTRATHECAL |
| 220014341 | 220014753 | null | 78 | Adjuvant (A) | 2017-05-31 | 2017-05-31 | Alemtuzumab cond (RI ALLO CAMP100) | Y | null | 220033414 | ALEMTUZUMAB |
| 220014342 | 220014753 | 1.57 | 54.6 | Curative (C) | 2017-12-25 | 2017-12-30 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220033414 | OXALIPLATIN + MDG |
| 220014343 | 220014753 | null | 83.6 | Curative (C) | 2015-06-07 | 2015-06-22 | Cytarabine intrathecal | Y | N | 220033414 | CYTARABINE INTRATHECAL |
| 220014344 | 220014753 | 1.65 | 94 | Palliative (P) | 2017-09-28 | 2017-10-03 | METHOTREXATE | Y | N | 220033414 | OXALIPLATIN + MDG |
| 220014345 | 220014753 | 1.67 | 95.1 | Curative (C) | 2013-05-26 | 2013-07-07 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 220033414 | CARBOPLATIN + PACLITAXEL |
| 220014346 | 220008874 | 1.86 | 72.4 | Disease modification (D) | 2015-06-21 | 2015-07-01 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | N | 220033438 | PONATINIB |
| 220014347 | 220008874 | 1.62 | 130 | Curative (C) | null | 2014-03-14 | GEMTUZUMAB OZOGAMICIN | 1 | N | 220033438 | UKALL2014 |
| 220014348 | 220008876 | 1.55 | 72 | Curative (C) | 2014-12-22 | 2014-12-23 | Arsenic trioxide + Tretinoin | N | null | 220033442 | ARSENIC TRIOXIDE + TRETINOIN |